Pharmaceutical group · Germany
Schering
A group of 18 companies with 97 medicines in 1 country.
Group structure
18 companies in 7 countries
Loading…
Pharmaceutical group · Germany
A group of 18 companies with 97 medicines in 1 country.
18 companies in 7 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 97
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AKRINOL2mg/gm · Cream | Acrisorcin | United States | Not marketed | |
| BETAPAR4MG · Tablet | Meprednisone | United States | Not marketed | |
| CELESTONE0.2% · Cream | Betamethasone | United States | Not marketed | |
| CELESTONE0.6mg · Tablet | Betamethasone | United States | Not marketed | 1961 |
| CELESTONE3MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Betamethasone | United States | Not marketed | 1974 |
| CHLOR-TRIMETON4MG · Tablet | Chlorpheniramine | United States | Not marketed | 1949 |
| CHLOR-TRIMETON2mg/5ml · Syrup | Chlorpheniramine | United States | Not marketed | 1949 |
| CLARINEX0.5mg/ml · Syrup | Desloratadine | United States | Marketed | 2004 |
| CLARINEX5MG · Tablet | Desloratadine | United States | Marketed | 2001 |
| DIPROLENE0.05% base · Gel, augmented | Betamethasone | United States | Not marketed | 1986 |
| DIPROLENE0.05% base · Cream, augmented | Betamethasone | United States | Not marketed | 1986 |
| DIPROSONE0.1% base · Disc | Betamethasone | United States | Not marketed | |
| DIPROSONE0.05% base · Ointment | Betamethasone | United States | Not marketed | 1976 |
| DIPROSONE0.05% base · Cream | Betamethasone | United States | Not marketed | 1975 |
| DIPROSONE0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Lotion | Betamethasone | United States | Not marketed | 1977 |
| DISOMER2mg/5ml · Syrup | Dexbrompheniramine | United States | Not marketed | |
| DISOMER2MG · Tablet | Dexbrompheniramine | United States | Not marketed | |
| DISOPHROL2mg; 60mg · Tablet | Dexbrompheniramine, Pseudoephedrine | United States | Not marketed | |
| ESTINYL0.02mg | 0.05mg | 0.5mg · Tablet | Ethinyl estradiol | United States | Not marketed | 1943 |
| ETRAFON 2-1010MG; 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Amitriptyline, Perphenazine | United States | Not marketed | 1969 |
| ETRAFON 2-2525MG; 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Amitriptyline, Perphenazine | United States | Not marketed | 1969 |
| ETRAFON-A10MG; 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Amitriptyline, Perphenazine | United States | Not marketed | 1969 |
| ETRAFON-FORTE25MG; 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Amitriptyline, Perphenazine | United States | Not marketed | 1969 |
| EULEXIN125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Flutamide | United States | Not marketed | 1989 |
| GARAMYCIN10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 40MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Gentamicin | United States | Not marketed | 1973 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 97 | 93 | 4 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Keep Schering’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.